These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 14300296)

  • 21. Experiences in mass prevention of measles by vaccination.
    Perkins FT
    Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
    [No Abstract]   [Full Text] [Related]  

  • 22. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 23. IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINES: FIVE YEARS' EXPERIENCE.
    KATZ SL
    Arch Gesamte Virusforsch; 1965; 16():222-30. PubMed ID: 14322868
    [No Abstract]   [Full Text] [Related]  

  • 24. FURTHER OBSERVATIONS ON IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINE BY INHALATION.
    OKUNO Y
    Arch Gesamte Virusforsch; 1965; 16():294-9. PubMed ID: 14322881
    [No Abstract]   [Full Text] [Related]  

  • 25. [IMMUNIZATION AGAINST MEASLES; ATTENUATED VIRUS VACCINES VERSUS INACTIVATED VIRUS VACCINES].
    VERONESI R
    Pediatr Prat; 1964; 35():141-8. PubMed ID: 14239134
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to live attenuated measles vaccine in children with severe kwashiorkor.
    Powell GM
    Ann Trop Paediatr; 1982 Sep; 2(3):143-5. PubMed ID: 6191631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Field trial with a further attenuated live measles virus vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Kasahara N
    Jpn J Microbiol; 1973 Jan; 17(1):75-9. PubMed ID: 4540649
    [No Abstract]   [Full Text] [Related]  

  • 28. STUDIES ON KILLED AND ATTENUATED MEASLES VACCINES IN GENERAL PRACTICE.
    WATSON GI
    Br Med J; 1965 Jul; 2(5452):13-6. PubMed ID: 14305344
    [No Abstract]   [Full Text] [Related]  

  • 29. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 30. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the inoculation test of measles vaccine. 2. The results of the use of inactivated measles vaccine alone and combined inactivated and attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):344-55. PubMed ID: 6070597
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 35. VACCINATION BY RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE REA RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; NAGAHAMA H; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():81-4. PubMed ID: 14169587
    [No Abstract]   [Full Text] [Related]  

  • 36. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the live AIK measles virus vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of the virus and of measles vaccines (author's transl)].
    Profeta ML
    Ann Sclavo; 1979 Jun; 21 Suppl 1():377-83. PubMed ID: 117758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR
    Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.